Development of coagulation regulatory proteins in the fetal and neonatal lamb

Pediatric Research

Volumn 52, Issue 4, 2002, Pages 580-588

  Manco Johnson, Marilyn J ^a   Jacobson, Linda J ^a   Hacker, Michele R ^a   Townsend, Susan F ^a   Murphy, James ^a   Hay Jr , William ^a  

^a Mountain States Regional Hemophilia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; PROTEIN C; PROTEIN S; REGULATOR PROTEIN; VITAMIN K GROUP;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; FETUS; GESTATIONAL AGE; LAMB; LIVER; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SHEEP;

EID: 0036787989     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200210000-00019     Document Type: Article

References (54)

1. Manco-Johnson M, Nuss R 2000 Hemostasis in the neonate. Neoreviews 1:e191-e195
2. Hathaway WE, Bonnar J 1987 Hemostatic disorders of the pregnant woman and newborn infant. Elsevier Science Publishing Company, New York, pp 57-75
3. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y 1996 Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 88:900-906
4. Nardi M, Karpatkin M 1986 Prothrombin and protein C in early childhood: normal adult levels are not achieved until the fourth year of life. J Pediatr 109:843-845
5. Andrew M, Paes B, Johnston M 1990 Development of the haemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12:95-104
6. Manco-Johnson MJ, Marlar RA, Jacobson LJ, Hays T, Warady BA 1988 Severe protein C deficiency in newborn infants. J Pediatr 113:359-363
7. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA 1991 Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 119:793-98
8. Andrew ME, Monagle P, deVeber G. Chan AKC 2001 Thromboembolic disease and antithrombotic therapy in newborns. Hematology (Am Soc Hematol Educ Program) Jan:358-374
9. Clauss LH, Comp PC 1986 The regulation of hemostasis:the protein C system. N Engl J Med 314:1298-1304
10. Marlar RA, Montgomery RR, Broekmans AW 1989 Diagnosis and treatment of homozygous protein C deficiency. J Pediatr 114:528-534
11. Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA 1989 Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol Oncol 11:395-401
12. Rosenberg RD, Damus PS 1973 The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 248:6490-6505
13. McDonald MM, Hathaway WE, Reeve EB, Leonard BD 1982 Biochemical and functional study of antithrombin III in newborn infants. Thromb Haemost 47:56-58
14. McDonald MM, Hathaway WE 1982 Anticoagulant therapy by continuous heparinization in newborn and older infants. J Pediatr 101:451-457
15. McDonald MM, Jacobson LJ, Hay WW, Hathaway WE 1981 Heparin clearance in the newborn. Pediatr Res 15:1015-1018
16. Manco-Johnson MJ 1989 Neonatal antithrombin III deficiency. Am J Med 87:49S-52S
17. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, Takeda N, Ito M, Yamamoto K, Matsushita T, Kusugami K, Muramatsu T, Saito H 2000 Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 106:873-878
18. Sanchez J, Velasco F, Alvarez R, Roman J, Torres A 1996 Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment. Acta Paediatr 85:245-247
19. Jochmans K, Lissens W, Vervoort R, Peeters S, De Waele M, Liebaers 1 1994 Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 83:146-151
20. Kisker CT 1987 The animal models for hemorrhage and thrombosis in the neonate. Thromb Haemost 57:118-122
21. Manco-Johnson MJ, Spedale S, Peters M, Townsend SF, Jacobson LJ, Christian J, Krugman SD, Hay WW, Sparks JW 1995 Identification of a unique form of protein C in the ovine fetus: developmentally linked transition to the adult form. Pediatr Res 37:365-372
22. Manco-Johnson MJ, Carver T, Jacobson LJ, Townsend SF, Hay WW 1994 Hyperglycemia-induced hyperinsulinemia decreases maternal and fetal plasma protein C concentration during ovine gestation. Pediatr Res 36:293-299
23. Baker DC, Ropbbe SL, Jacobson LJ, Manco-Johnson MJ, Holler L, Lefkowitz J 1999 Hereditary deficiency of vitamin-K-dependent coagulation factors in Rambouillet sheep. Blood Coagul Fibrinolysis 10:75-80
24. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1162:156-159
25. Reynolds ML, Evans CAN, Reynolds EOR, Saunders NR, Durbin GM, Wigglesworth JS 1979 Intracranial haemorrhage in the preterm sheep fetus. Early Hum Dev 3:163-186
26. Kisker CT, Robillard JE, Clarke W 1981 Development of blood coagulation-a fetal lamb model. Pediatr Res 15:1045-1050
27. Kisker CT, Robillard JE, Clarke W 1982 Blood coagulation changes after hypoxemia: a fetal lamb model. Pediatr Res 16:8-12
28. Kisker CT, Robillard JE, Clarke W 1982 Blood coagulation changes following hypoxemia in the near-term fetal lamb. Pediatr Res 16:732-739
29. Kisker CT, Bohlken DP, Clarke WR 1985 Effects of acidosis on fetal and maternal blood coagulation: a fetal lamb model. Pediatr Res 19:78-82
30. Moalic P, Gruel Y, Body G, Foloppe P, Delahousse B, LeRoy J 1988 Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns. Thromb Res 49:471-480
31. Karpatkin M, Lee M, Cohen L. McKinnell J, Nardi M 2000 Sythesis of coagulation proteins in the fetus and neonate. J Pediatr Hematol Oncol 22:276-280
32. Reijnen MJ, Peerlinck K, Maasdam D, Bertina RM, Reitsma PH 1993 Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor binding site in the factor IX promoter. Blood 82:151-158
33. Boccia LM, Lillicrap D, Newcombe K, Mueller CR 1996 Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation. Mol Cell Biol 16:1929-1935
34. Avery ME 1975 Pharmacologic approach to the acceleration of fetal lung maturation. Br Med Bull 31:13-17
35. Kisker CT, Robillard JE, Bohlken DP 1983 Glucocorticoid stimulation of blood coagulation factor activities in the fetal lamb. J Lab Clin Med 101:569-575
36. Xanthopoulos KG, Mirkovitch J 1993 Gene regulation in rodent hepatocytes during development, differentiation and disease. Eur J Biochem 216:353-360
37. Kawamoto S, Matsumoto Y, Miuno K, Okubo K, Matsubara K 1996 Expression profiles of active genes in human and mouse livers. Gene 174:151-158
38. Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, Davidson S, Xu H, Chen A, Yamanishi DT, Lindemann GW, Cain CA, Madlansacay MR, Hashima SM, Pham TL, Mahoney W, Schueler PA 1999 Identification of differentially expressed mRNAs in human liver across gestation. Nucleic Acids Res 27:839-847
39. Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, Russo G, Mannucci PM, Peschle C 1990 Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 76:1158-1164
40. Karpatkin M, Blei F, Hurlet A, Greco A, Tang Z 1991 Prothrombin expression in the adult and fetal rabbit liver. Pediatr Res 30:266-269
41. Cohen L, McKinnell J, Puglisi V, Greco A, Nardi M, Lee M, Karpatkin M 1997 Prothrombin synthesis in the adult and fetal liver. Thromb Haemost 78:1468-1472
42. Francis JL, Armstrong DJ 1982 Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostasis 11:223-228
43. Andrew M, Mitchell L, Berry LR, Schmidt B, Hattou MW 1998 Fibrinogen has a rapid turnover in the healthy newborn lamb. Pediatr Res 23:249-252
44. Thompson AR 1977 Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B. J Clin Invest 59:900-910
45. Vigano S, Mannucci PM, Solinas S, Bottasso B, Mariani G 1984 Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy. Br J Haematol 57:213-220
46. Takahashi H, Hanano M, Hayashi S, Arai Y, Yoshino N, Takakuwa E, Tatewaki W, Nagayama R, Takizawa S, Shibata A 1986 Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy. Tohoku J Exp Med 149:351-357
47. Weiss P, Soff GA, Halkin H, Seligsohn U 1987 Decline of proteins C and S and factors II, VII, IX and X during initiation of warfarin therapy. Thromb Res 45:783-790
48. Jamison CS, Burkey BF, Degen SJ 1992 The effects of vitamin K1 and warfarin on prothrombin expression in human hepatoblastoma (HepG2) cells. Thromb Haemost 68:40-47
49. Vermeer C 1984 The vitamin K-dependent carboxylation reaction. Mol Cell Biochem 61:17-35
50. Wallin R, Stanton C, Hutson SM 1993 Intracellular maturation of the gammacarboxyglutamic acid region in prothrombin coincides with release of the propeptide. Biochem J 291:723-727
51. Shearer MJ, Rahim S, Barkhan P, Stimmler L 1982 Plasma vitamin K1 in mothers and their newborn babies. Lancet 2:460-463
52. Mandelbrot L, Guillaumont M, Leclercq M, Lefrere JJ, Gozin D, Daffos F, Forestier F 1988 Placental transfer of vitamin K1 and its implications in fetal hemostasis. Thromb Haemost 60:39-43
53. Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane P, Hathaway WE 1986 Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 109:675-680
54. Israels LG, Israels ED 1995 Observations on vitamin K deficiency in the fetus and newborn: has nature made a mistake? Semin Thromb Hemost 21:357-363